- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05978154
Thigh Muscle Mass and Muscle Wasting in Patients in the Emergency Department
July 28, 2023 updated by: Ahn, Sejoong, Korea University Ansan Hospital
The goal of this observational study is to evaluate whether thigh muscle mass and muscle wasting are associated with mortality in patients who visit the emergency department. The main questions it aims to answer are:
- Is thigh muscle mass associated with mortality in patient who visit the emergency department?
- Does muscle wasting exist during staying in the emergency department?
- Is muscle wasting associated with mortality in patient who visit the emergency department? Participants will be evaluated for serial thigh muscle mass using point-of-care ultrasound at the emergency department.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
600
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sejoong Ahn
- Phone Number: 82-10-2946-0250
- Email: sejongahn@naver.com
Study Locations
-
-
Gyeonggi-do
-
Ansan-si, Gyeonggi-do, Korea, Republic of, 15355
- Recruiting
- Korea University Ansan Hospital
-
Contact:
- Sejoong Ahn
- Email: sejoongahn@naver.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Patients who visit the emergency department with informed consent and then who undergo point-of-care ultrasound to evaluate thigh muscle mass.
Description
Inclusion Criteria:
- patients who visit the emergency department of Korea University Ansan Hospital during study period
- patients with age within the limits
- patients who are willing to be participate the study with informed consent
- patients who undergo point-of-care ultrasound to evaluate thigh muscle mass
Exclusion Criteria:
- patients with age out of limits
- patients who have deformities on lower leg
- patients who is unable to maintain appropriate position to undergo point-of-care ultrasound
- patients who decline to participate the study
- patients who have 'do-not-resuscitate' order or are not willing to be resuscitated
- patients of whom point-of-care ultrasound on thigh muscle mass was not performed
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
28 day mortality
Time Frame: 28 days after study enrollment
|
28 day mortality
|
28 days after study enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 28, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
March 31, 2025
Study Registration Dates
First Submitted
July 28, 2023
First Submitted That Met QC Criteria
July 28, 2023
First Posted (Actual)
August 7, 2023
Study Record Updates
Last Update Posted (Actual)
August 7, 2023
Last Update Submitted That Met QC Criteria
July 28, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- musclemassandwastingined
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
Rennes University HospitalUnknownSevere Sepsis or Septic Shock
Clinical Trials on Thigh muscle mass and muscle wasting (exposure)
-
Rigshospitalet, DenmarkMerck Sharp & Dohme LLC; Roche Pharma AG; Beckett Foundation; Onkologisk ForskningsfondUnknownUrinary Bladder NeoplasmDenmark
-
Nanjing Medical UniversityCompletedFrailty | Sarcopenia | Gastric (Stomach) Cancer | Malnutrition ElderlyChina
-
Centre Hospitalier Universitaire de NiceCompleted
-
Boston Children's HospitalAcademy of Nutrition and DieteticsRecruitingCongenital Heart Disease | ICU Acquired Weakness | Catabolic StateUnited States
-
University Department of Geriatric Medicine FELIX...RecruitingSarcopenia | Osteoporosis | Muscle LossSwitzerland
-
Wuerzburg University HospitalRecruitingMusic Performance AnxietyGermany
-
Universiti Tunku Abdul RahmanCompletedSarcopenia | Sarcopenic Obesity
-
University Hospital TuebingenUniversity of RegensburgCompleted
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingObstructive Sleep ApneaUnited States